Charles Carroll Financial Partners LLC Decreases Stake in CVS Health Co. (NYSE:CVS)

Charles Carroll Financial Partners LLC lessened its stake in shares of CVS Health Co. (NYSE:CVS) by 38.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,765 shares of the pharmacy operator’s stock after selling 1,700 shares during the quarter. Charles Carroll Financial Partners LLC’s holdings in CVS Health were worth $218,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in CVS. Atticus Wealth Management LLC raised its stake in shares of CVS Health by 149.0% during the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after acquiring an additional 219 shares during the last quarter. Cornerstone Planning Group LLC grew its position in shares of CVS Health by 111.5% in the 3rd quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 243 shares during the last quarter. ZRC Wealth Management LLC increased its stake in shares of CVS Health by 400.0% during the fourth quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock valued at $39,000 after buying an additional 400 shares during the period. Coston McIsaac & Partners lifted its stake in CVS Health by 42.6% in the fourth quarter. Coston McIsaac & Partners now owns 539 shares of the pharmacy operator’s stock worth $42,000 after acquiring an additional 161 shares during the period. Finally, Tennessee Valley Asset Management Partners bought a new stake in CVS Health in the fourth quarter valued at $50,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Stock Up 1.4 %

NYSE CVS traded up $0.75 during mid-day trading on Friday, reaching $55.90. The stock had a trading volume of 23,946,075 shares, compared to its average volume of 12,498,538. The stock has a market cap of $70.18 billion, a PE ratio of 9.82, a price-to-earnings-growth ratio of 0.88 and a beta of 0.56. CVS Health Co. has a 1 year low of $53.70 and a 1 year high of $83.25. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.81 and a quick ratio of 0.63. The company has a fifty day moving average price of $72.77 and a 200 day moving average price of $73.26.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share for the quarter, missing the consensus estimate of $1.69 by ($0.38). CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The business had revenue of $88.44 billion during the quarter, compared to analysts’ expectations of $89.33 billion. During the same quarter in the prior year, the firm earned $2.20 EPS. The firm’s revenue for the quarter was up 3.7% compared to the same quarter last year. On average, research analysts expect that CVS Health Co. will post 7.03 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd were paid a $0.665 dividend. The ex-dividend date was Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.76%. CVS Health’s dividend payout ratio is presently 46.75%.

Insider Activity

In related news, EVP Prem S. Shah sold 29,473 shares of the firm’s stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $76.95, for a total value of $2,267,947.35. Following the sale, the executive vice president now owns 39,765 shares in the company, valued at $3,059,916.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other CVS Health news, Director Edward J. Ludwig purchased 1,000 shares of CVS Health stock in a transaction dated Thursday, May 2nd. The stock was purchased at an average price of $53.88 per share, with a total value of $53,880.00. Following the transaction, the director now directly owns 21,630 shares of the company’s stock, valued at $1,165,424.40. The purchase was disclosed in a document filed with the SEC, which is available through this link. Also, EVP Prem S. Shah sold 29,473 shares of the firm’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the completion of the transaction, the executive vice president now directly owns 39,765 shares in the company, valued at approximately $3,059,916.75. The disclosure for this sale can be found here. 0.24% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

CVS has been the subject of several research reports. Leerink Partnrs cut shares of CVS Health from an “outperform” rating to a “market perform” rating in a research report on Wednesday. StockNews.com lowered shares of CVS Health from a “buy” rating to a “hold” rating in a report on Thursday, February 15th. Bank of America reduced their target price on CVS Health from $95.00 to $77.00 and set a “buy” rating on the stock in a report on Thursday. Cantor Fitzgerald cut CVS Health from an “overweight” rating to a “neutral” rating and lowered their target price for the company from $87.00 to $58.00 in a research note on Wednesday. Finally, Barclays reduced their price target on CVS Health from $78.00 to $63.00 and set an “equal weight” rating on the stock in a research note on Thursday. Eight research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and an average price target of $80.35.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.